Delivery Order SPE2DB22D1103-SPE2DB24FTHE0
- Not listed
- This federal contract award is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,238.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract has an ultimate completion date of April 3, 2024 and does not include a set-aside designation....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,091.40 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical product. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is a firm fixed price delivery order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a potential value of $1,850.73 and a completion date of February 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The $15,436.60 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency customer for Amerisourcebergen. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 30, 2024. This award is likely part of a larger indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $3,458.89 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply fluticasone propionate HFA 220 MCG 12GM to military treatment facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $6,130.55 firm fixed price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,200.66 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 110 mcg 12gm pharmaceutical products. The contract has a potential value of $2,124.52 and a period of performance through February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not...
- This federal contract award, valued at $3,376.27, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award is a firm fixed price delivery order for the supply of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTHE0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $3,562.28 firm fixed price delivery order for the supply of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 3/26/24 |